Form 4: Ecolab Director Lionel L. Nowell, III, Reports Stock Option Grant

Director Lionel L. Nowell, III, reports the acquisition of a stock option for 934 shares of Ecolab common stock.

Summary

• On May 6, 2024, Lionel L. Nowell, III, a director of Ecolab Inc., reported a transaction involving derivative securities.
• Nowell acquired a non-employee director stock option (right to buy) for 934 shares of Ecolab common stock at a price of $228.255.
• The option becomes exercisable in stages, with 25% vesting every three months, starting August 6, 2024, and fully vested after twelve months.
• The option will become immediately exercisable in full if a Change in Control of the Company occurs.
• Following the reported transaction, Nowell directly owns 934 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction that aligns director interests with shareholders through equity ownership.

Positives

• The grant of stock options to directors aligns their interests with those of shareholders.
• The vesting schedule incentivizes long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock option.

Industry Context

Stock options are a common form of compensation for directors, aligning their interests with the long-term performance of the company. This filing is a routine disclosure of such compensation.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary widely across industries and company sizes.
• Comparing Ecolab's director compensation to that of its peers (e.g., companies like Procter & Gamble, Clorox, or Dow Chemical) would provide a better understanding of whether the option grant is in line with industry standards.
• Factors such as company performance, market capitalization, and the director's role influence the size and structure of these grants.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
• The vesting schedule may incentivize the director to remain engaged with the company over the long term.

Key Dates